Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
Guan-Hua Su(Shanghai Medical College of Fudan University), Yajia Gu(Fudan University Shanghai Cancer Center), He Wang(Anhui Medical University), Yan Chen(University of Nottingham), Chao You(Fudan University Shanghai Cancer Center), Yi Xiao(Shanghai Medical College of Fudan University), Rencheng Zheng(Shanghai Center for Brain Science and Brain-Inspired Technology), Lin Jiang(Fudan University Shanghai Cancer Center)
Cited by 64
Related Papers
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiomics in breast cancer: Current advances and future directions
|Cell Reports Medicine|2024|143
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
|Science Advances|2023|114
Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
|Cell Reports Medicine|2022|92